MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
CLVLF
Stock ticker: OTC
PRICE
CHANGE
CAPITALIZATION

Clinuvel Pharmaceuticals (CLVLF) Ownership - Who owns Clinuvel Pharmaceuticals?

Clinuvel distributes a single product, Scenesse, the only approved treatment for phototoxic reactions specifically associated with a rare genetic disease called erythropoietic protoporphyria... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
N/A
Address
535 Bourke Street
Phone
+61 396604900
Employees
16
Web
https://www.clinuvel.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
344.61M
P/E Ratio
15.34
Total Cash
N/A
Projected Growth
N/A
Total Debt
N/A
Revenue
91.57M
Risk (Beta)
0.53
Dividend Yield
0.00
Total Cash/Share
N/A
Total Debt/Equity
N/A
Revenue/Share
1.16 USD as % of share price

Fundamentals

CLVLF
Capitalization
345M
P/E Ratio
15.34
Risk (Beta)
0.53
Dividend Yield
0.00
Total Cash
N/A
Total Cash/Share
N/A
Total Debt
N/A
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
1.16%
Revenue
91.6M
ROE
N/A
Book Value
N/A
P/B Ratio
2.70
Cash Flow
N/A
Earnings
0.77
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
N/A
Current Ratio
N/A
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
63.4M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
17.32
Shares Held By Institutions
56.1M
Shares Outstanding - Current
50.1M
Total Liabilities
N/A
Total Volume MTD
N/A
Value
1
Gain YTD
-11.893
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
535 Bourke Street
Phone
+61 396604900
Employees
16
Web
https://www.clinuvel.com